Developing TCR & CAR Targeted Engineered Treg Cells for Autoimmune Diseases
Time: 11:00 am
day: Autoimmune Focus Day Pt 2
Details:
• Developing TCR targeted EngTreg GNTI-122 for Type 1 Diabetes
• CAR discovery for EngTreg therapy to treat inflammatory bowel disease
• CAR EngTregs for other autoimmune diseases
